Abberant splicing more common in cancer

ETH scientists just published a paper in Cancer Cell which demonstrates that abberant splicing in cancer is more frequent than was believed. This may have significant impact on the MHC neo-antigen landscape driving T cell responses. #immunotherapy #immunopeptidome #precisionmedicine

https://www.ethz.ch/en/news-and-events/eth-news/news/2018/08/hidden-signs-in-cancer-tissue.html

要查看或添加评论,请登录

Tim Fugmann的更多文章

社区洞察

其他会员也浏览了